Mineralocorticoid receptor mediates heart failure in the 11ß-hydroxysteroid dehydrogenase type 2 transgenic mouse model

被引：0
作者：
Qin, WN
Bond, BR
Donoho, GP
Heyen, JR
Frierdich, GE
Bolten, CW
Funder, JW
McMahon, EG
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Pfizer Inc, St Louis, MO USA
[3] Pfizer Inc, Kalamazoo, MI USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Prince Henrys Inst Med Res, Melbourne, Vic, Australia
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
[41]   Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency [J].
Yau, Mabel ;
Haider, Shozeb ;
Khattab, Ahmed ;
Ling, Chen ;
Mathew, Mehr ;
Zaidi, Samir ;
Bloch, Madison ;
Patel, Monica ;
Ewert, Sinead ;
Abdullah, Wafa ;
Toygar, Aysenur ;
Mudryi, Vitalii ;
Al Badi, Maryam ;
Alzubdi, Mouch ;
Wilson, Robert C. ;
Al Azkawi, Hanan Said ;
Ozdemir, Hatice Nur ;
Abu-Amer, Wahid ;
Hertecant, Jozef ;
Razzaghy-Azar, Maryam ;
Funder, John W. ;
Al Senani, Aisha ;
Sun, Li ;
Kim, Se-Min ;
Yuen, Tony ;
Zaidi, Mone ;
New, Maria I. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (52) :E11248-E11256
[42]   Role of 11β-Hydroxysteroid Dehydrogenase and Mineralocorticoid Receptor on Alzheimer's Disease Onset: A Systematic Review [J].
Di Vincenzo, Mariangela ;
Pellegrino, Pamela ;
Schiappa, Genny ;
Campanati, Anna ;
Del Vescovo, Valerio ;
Piccirillo, Silvia ;
Ambrogini, Patrizia ;
Arnaldi, Giorgio ;
Orciani, Monia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
[43]   Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists [J].
Pandya, Keyur ;
Dietrich, David ;
Seibert, Julia ;
Vederas, John C. ;
Odermatt, Alex .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (21) :6274-6281
[44]   Chenodeoxycholic acid and deoxycholic acid inhibit 11β-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor [J].
Stauffer, AT ;
Rochat, MK ;
Dick, B ;
Frey, FJ ;
Odermatt, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26286-26292
[45]   Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by organotins [J].
Nashev, LG ;
Atanasov, AG ;
Tam, S ;
Baker, ME ;
Odermatt, A .
FASEB JOURNAL, 2005, 19 (04) :A94-A94
[46]   Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2 [J].
Ma, Xue ;
Lian, Qing-Quan ;
Dong, Qiang ;
Ge, Ren-Shan .
TOXICOLOGY, 2011, 285 (03) :83-89
[47]   11β-hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia [J].
Causevic, Maja ;
Mohaupt, Markus .
MOLECULAR ASPECTS OF MEDICINE, 2007, 28 (02) :220-226
[48]   Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNA [J].
Rezaei, Mina ;
Andrieu, Thomas ;
Neuenschwander, Samuel ;
Bruggmann, Remy ;
Mordasini, David ;
Frey, Felix J. ;
Vogt, Bruno ;
Frey, Brigitte M. .
HYPERTENSION, 2014, 64 (04) :860-+
[49]   Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates [J].
Atanasov, AG ;
Tam, S ;
Röcken, JM ;
Baker, ME ;
Odermatt, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :257-262
[50]   Furosemide inhibits 11β-hydroxysteroid dehydrogenase type 2 [J].
Fuster, D ;
Escher, G ;
Vogt, B ;
Ackermann, D ;
Dick, B ;
Frey, BM ;
Frey, FJ .
ENDOCRINOLOGY, 1998, 139 (09) :3849-3854
12345